GMDA News and Press, Gamida Cell Ltd. From 05/11/21

Gamida Cell (GMDA): Q1 GAAP EPS of -$0.34 beats by $0.06.Cash and cash equivalents of $174.8M.Press Release For further details see: Gamida Cell EPS beats by $0.06

BLA submission for omidubicel, a potentially life-saving treatment for patients with blood cancers in need of stem cell transplant, expected in fourth quarter of 2021 Pre-commercial and manufacturing activities underway to support potential launch of omidubicel in 2022 ...

Gainers: [[DTEA]] +10.5%. [[RAIL]] +4.4%. [[GMDA]] +4.3%. [[CHEF]] +3.1%. [[VTRU]] +3.1%.Losers: [[SATS]] -3.7%. [[BLCT]] -2.7%. [[VIACP]] -2.5%. [[MVIS]] -2.1%. [[HTLD]] -2.0%. For further details see: DTEA, GMDA, MVIS and SATS among after-hours movers

The following slide deck was published by Gamida Cell Ltd. in conjunction with this event. For further details see: Gamida Cell (GMDA) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Ph. D., chief executive officer of Gamida Cell, will present at the 20 th Annual Needham Virtual Healthcare Conferenc...

-Abstract will be shared at Presidential Symposium and featured in this year’s “Live with Best Abstracts” session- Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, to...

Image source: The Motley Fool. Gamida Cell Ltd. (NASDAQ: GMDA) Q4 2020 Earnings Call Mar 09, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Gamida Cell Ltd. (GMDA) Q4 2020 Earnings Call Transcript

The following slide deck was published by Gamida Cell Ltd. in conjunction with their 2020 Q4 earnings call. For further details see: Gamida Cell Ltd. 2020 Q4 - Results - Earnings Call Presentation

Gamida Cell Ltd. (GMDA) Q4 2020 Results Conference Call March 09, 2021 08:30 AM ET Company Participants Josh Hamermesh - Chief Business Officer Julian Adams - CEO Ronit Simantov - Chief Medical Officer Shai Lankry - CFO Michele Korfin - COO and Chief Commercial Officer Tracey Lodie - Chief Sc...

Gamida ([[GMDA]] +4.7%) Q4 net loss for 2020 was $72.7M, compared to a net loss of $34.4M in 2019.GAAP EPS of -$1.66 misses consensus by $0.35.R&D expenses in 2020 were $41.4M, compared to $31.5M in 2019.As of December 31, 2020, had total cash and cash equivalents of $127.2 mill...